Investing
Opening Bell Analysts Research Calls for Tuesday, February 21
Published:
This report was sent to Briefing.com subscribers earlier today. https://briefing.com
Research calls posted earlier this morning are available here.
> Alliant Energy (LNT) upgraded to Neutral from Sell at Guggenheim; tgt raised to $52
> Glacier Bancorp (GBCI) upgraded to Outperform from Mkt Perform at Raymond James; tgt $51
> HomeTrust Bank (HTBI) upgraded to Buy from Neutral at Janney
> Lakeland Financial (LKFN) upgraded to Outperform from Mkt Perform at Raymond James; tgt $78
> MarineMax (HZO) upgraded to Buy from Neutral at B. Riley Securities; tgt lowered to $52
> Prosperity Bancshares (PB) upgraded to Outperform from Mkt Perform at Raymond James; tgt $85
> Travere Therapeutics (TVTX) upgraded to Outperform from Neutral at Wedbush; tgt $30
> Trustmark (TRMK) upgraded to Outperform from Mkt Perform at Raymond James; tgt $34
> Actinum Pharma (ATNM) downgraded to Mkt Perform from Outperform at William Blair
> American Equity Investment Life (AEL) downgraded to Neutral from Overweight at Piper Sandler; tgt raised to $48
> Annaly Capital Mgmt (NLY) downgraded to Hold from Buy at Argus
> Axos Financial (AX) downgraded to Outperform from Strong Buy at Raymond James; tgt $55
> Cable ONE (CABO) downgraded to Underweight from Equal Weight at Wells Fargo; tgt lowered to $680
> Claros Mortgage Trust (CMTG) downgraded to Mkt Perform from Mkt Outperform at JMP Securities
> Cullen/Frost (CFR) downgraded to Mkt Perform from Outperform at Raymond James
> First Commonwealth (FCF) downgraded to Mkt Perform from Outperform at Raymond James
> First Merchants (FRME) downgraded to Outperform from Strong Buy at Raymond James; tgt $50
> Focus Financial (FOCS) downgraded to Hold from Buy at Truist; tgt raised to $53
> Generac (GNRC) downgraded to Hold from Buy at Truist; tgt $145
> Kinsale Capital (KNSL) downgraded to Neutral from Buy at Compass Point; tgt $350
> Origin Bancorp (OBNK) downgraded to Outperform from Strong Buy at Raymond James; tgt lowered to $43
> RE/MAX Holdings (RMAX) downgraded to Equal-Weight from Overweight at Stephens; tgt lowered to $21
> Albemarle (ALB) initiated with a Market Perform at CICC
> Alnylam Pharma (ALNY) initiated with a Buy at EF Hutton; tgt $304
> BioMarin Pharmaceutical (BMRN) initiated with a Neutral at Citigroup; tgt $116
> Oncternal Therapeutics (ONCT) assumed with a Buy at Brookline; tgt $6
> Ryan Specialty Group (RYAN) initiated with an Underperform at Autonomous; tgt $35
> TXO Energy Partners (TXO) initiated with a Strong Buy at Raymond James; tgt $34
> TXO Energy Partners (TXO) initiated with an Overweight at CapitalOne; tgt $35
> Workday (WDAY) named Catalyst Call Buy Idea at Deutsche Bank
Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply
clicking here you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.